Nu Skin Enterprises Inc. (NUS) Tops Q3 EPS by 11c, Raises Q4, FY11 Guidance, Posts FY12
Nu Skin Enterprises Inc. (NYSE: NUS) reported Q3 EPS of $0.72, $0.11 better than the analyst estimate of $0.61. Revenue for the quarter came in at $428 million versus the consensus estimate of $415.57 million.
Nu Skin Enterprises Inc. sees Q4 2011 EPS of $0.66-$0.70, versus the consensus of $0.66. Nu Skin Enterprises Inc. sees Q4 2011 revenue of $465-$475 million, versus the consensus of $415.57 million.
Nu Skin Enterprises Inc. sees FY2011 EPS of $2.27-$2.31, versus the consensus of $2.48. Nu Skin Enterprises Inc. sees FY2011 revenue of $1.714-$1.724 billion, versus the consensus of $1.68 billion.
will provide detailed 2012 guidance to shareholders on November 16th at our annual investor day as we will have a better feel for the impact of the product launch by that time. However, our initial 2012 guidance anticipates revenue of $1.79 billion to $1.82 billion, assuming a slightly negative currency impact, with earnings per share of $2.80 to $2.90," concluded Wood.
Nu Skin Enterprises Inc. sees Q4 2011 EPS of $0.66-$0.70, versus the consensus of $0.66. Nu Skin Enterprises Inc. sees Q4 2011 revenue of $465-$475 million, versus the consensus of $415.57 million.
Nu Skin Enterprises Inc. sees FY2011 EPS of $2.27-$2.31, versus the consensus of $2.48. Nu Skin Enterprises Inc. sees FY2011 revenue of $1.714-$1.724 billion, versus the consensus of $1.68 billion.
will provide detailed 2012 guidance to shareholders on November 16th at our annual investor day as we will have a better feel for the impact of the product launch by that time. However, our initial 2012 guidance anticipates revenue of $1.79 billion to $1.82 billion, assuming a slightly negative currency impact, with earnings per share of $2.80 to $2.90," concluded Wood.